Jounce Therapeutics, Inc. (JNCE): Price and Financial Metrics


Jounce Therapeutics, Inc. (JNCE): $1.21

0.02 (+1.68%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add JNCE to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

JNCE Stock Price Chart Interactive Chart >

Price chart for JNCE

JNCE Price/Volume Stats

Current price $1.21 52-week high $8.80
Prev. close $1.19 52-week low $0.58
Day low $1.19 Volume 577,606
Day high $1.26 Avg. volume 878,673
50-day MA $0.97 Dividend yield N/A
200-day MA $2.82 Market Cap 62.55M

Jounce Therapeutics, Inc. (JNCE) Company Bio


Jounce Therapeutics, Inc. focuses on developing cancer immunotherapy treatments that enable the immune system to attack tumors. The company in 2012 and is based in Cambridge, Massachusetts.


JNCE Latest News Stream


Event/Time News Detail
Loading, please wait...

JNCE Latest Social Stream


Loading social stream, please wait...

View Full JNCE Social Stream

Latest JNCE News From Around the Web

Below are the latest news stories about JOUNCE THERAPEUTICS INC that investors may wish to consider to help them evaluate JNCE as an investment opportunity.

A stock that deserves closer examination: Jounce Therapeutics Inc. (JNCE)

As of Tuesday, Jounce Therapeutics Inc.’s (NASDAQ:JNCE) stock closed at $1.15, down from $1.23 the previous day. While Jounce Therapeutics Inc. has underperformed by -6.50%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JNCE fell by -81.89%, with highs and lows ranging from $8.80 to $0.58, […]

US Post News | January 18, 2023

Jounce Therapeutics Inc. (NASDAQ: JNCE) Down -83.45% This Year: What Is Going To Happen Next

Jounce Therapeutics Inc. (NASDAQ:JNCE) price closed higher on Tuesday, January 10, jumping 8.41% above its previous close. A look at the daily price movement shows that the last close reads $1.07, with intraday deals fluctuated between $1.05 and $1.17. The company’s 5Y monthly beta was ticking 1.28. Taking into account the 52-week price action we … Jounce Therapeutics Inc. (NASDAQ: JNCE) Down -83.45% This Year: What Is Going To Happen Next Read More »

Stocks Register | January 11, 2023

Wondrous stocks: Imperial Petroleum Inc. (NASDAQ:IMPP), Jounce Therapeutics, Inc. (NASDAQ:JNCE)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Wondrous stocks: Imperial Petroleum Inc. (NASDAQ:IMPP), Jounce Therapeutics, Inc. (NASDAQ:JNCE) appeared first on Stocks Equity .

Stock Equity | January 10, 2023

Jounce Therapeutics Inc. (NASDAQ:JNCE) Falls -4.92%, But An Additional Plunge May Follow.

In last trading session, Jounce Therapeutics Inc. (NASDAQ:JNCE) saw 1.9 million shares changing hands with its beta currently measuring 0.89. Company’s recent per share price level of $1.16 trading at -$0.06 or -4.92% at ring of the bell on the day assigns it a market valuation of $60.51M. That closing price of JNCE’s stock is … Jounce Therapeutics Inc. (NASDAQ:JNCE) Falls -4.92%, But An Additional Plunge May Follow. Read More »

Marketing Sentinel | January 6, 2023

Stock is blowing up: Jounce Therapeutics, Inc. (NASDAQ:JNCE), iBio, Inc. (AMEX:IBIO)

Jounce Therapeutics, Inc. (NASDAQ:JNCE) with the stream of -1.80% also noticed, India iBio, Inc. (AMEX:IBIO) encountered a rapid change of 48.51% in the last hour of Tuesday’s trading session. Jounce … The post Stock is blowing up: Jounce Therapeutics, Inc. (NASDAQ:JNCE), iBio, Inc. (AMEX:IBIO) appeared first on Stocks Equity .

Stock Equity | January 4, 2023

Read More 'JNCE' Stories Here

JNCE Price Returns

1-mo 11.01%
3-mo -38.89%
6-mo -70.91%
1-year -83.36%
3-year -81.53%
5-year -94.82%
YTD 9.01%
2022 -86.71%
2021 19.29%
2020 -19.82%
2019 159.05%
2018 -73.57%

Continue Researching JNCE

Want to see what other sources are saying about Jounce Therapeutics Inc's financials and stock price? Try the links below:

Jounce Therapeutics Inc (JNCE) Stock Price | Nasdaq
Jounce Therapeutics Inc (JNCE) Stock Quote, History and News - Yahoo Finance
Jounce Therapeutics Inc (JNCE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6979 seconds.